Anne Vestergaard
Overview
Explore the profile of Anne Vestergaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knausl B, Vestergaard A, Schwarz M, Muren L
Phys Imaging Radiat Oncol
. 2025 Jan;
33:100695.
PMID: 39866245
No abstract available.
2.
Laegdsmand P, Matysiak W, Muren L, Lassen-Ramshad Y, Maduro J, Vestergaard A, et al.
Phys Imaging Radiat Oncol
. 2025 Jan;
32():100675.
PMID: 39803348
Background And Purpose: Radiotherapy for paediatric posterior fossa tumours may cause complications in the brainstem and upper spinal cord due to high doses. With proton therapy (PT) this risk may...
3.
Tarp I, Taasti V, Jensen M, Vestergaard A, Jensen K
Phys Imaging Radiat Oncol
. 2024 Sep;
31:100632.
PMID: 39257572
Background And Purpose: The primary cause of range uncertainty in proton therapy is inaccuracy in estimating the stopping-power ratio from computed tomography. This study examined the impact on dose-volume metrics...
4.
Toussaint L, Matysiak W, Alapetite C, Aristu J, Bannink-Gawryszuk A, Bolle S, et al.
Radiother Oncol
. 2024 Jun;
198:110414.
PMID: 38942120
Background And Purpose: As no guidelines for pencil beam scanning (PBS) proton therapy (PT) of paediatric posterior fossa (PF) tumours exist to date, this study investigated planning techniques across European...
5.
Domingo Munoz I, Van Hoey O, Parisi A, Bassler N, Grzanka L, De Saint-Hubert M, et al.
Phys Med Biol
. 2024 May;
69(13).
PMID: 38774985
This work investigates the use of passive luminescence detectors to determine different types of averaged linear energy transfer (LET-) for the energies relevant to proton therapy. The experimental results are...
6.
Smulders B, Stolarczyk L, Seiersen K, Norrevang O, Sommer Kristensen B, Schut D, et al.
Acta Oncol
. 2023 Oct;
62(11):1541-1545.
PMID: 37793798
No abstract available.
7.
Tilbaek S, Petersen S, Stolarczyk L, Vestergaard A, Ronde H, Bentzen L, et al.
Acta Oncol
. 2023 Sep;
62(11):1455-1460.
PMID: 37773941
Background: Inter-fractional anatomical changes challenge robust delivery of whole-pelvic proton therapy for high-risk prostate cancer. Pre-treatment robust evaluation (PRE) takes uncertainties in isocenter shifts and distal beam edge in treatment...
8.
Tilbaek S, Paul Muren L, Vestergaard A, Stolarczyk L, Ronde H, Johansen T, et al.
Clin Transl Radiat Oncol
. 2023 Jul;
41:100632.
PMID: 37441541
The Danish Prostate Cancer Group is launching the randomized trial, PROstate PROTON Trial 1 (NCT05350475), that compares photons and protons to the prostate and pelvic lymph nodes in treatment of...
9.
Toussaint L, Brandal P, Embring A, Engellau J, Evensen M, Griskeviskius R, et al.
Acta Oncol
. 2021 Dec;
61(2):235-238.
PMID: 34970940
No abstract available.
10.
Hahn C, Oden J, Dasu A, Vestergaard A, Jensen M, Sokol O, et al.
Acta Oncol
. 2021 Oct;
61(2):206-214.
PMID: 34686122
Background: Clinical data suggest that the relative biological effectiveness (RBE) in proton therapy (PT) varies with linear energy transfer (LET). However, LET calculations are neither standardized nor available in clinical...